Skip to content

Journey Medical Corp

DERM· NasdaqCore metricsCIK 1867066

Pharmaceutical preparations552 peers

Last sale
Nov 12, 2026 · -1.91%
Market cap
$123.37M
28.23M shares
Filings
231
$18.93M
Q3 2026+10.2% FY25 yoy
-$1.32M
Q3 2026N/M FY25 yoy
-$530.00K
Q3 2026N/M FY25 yoy
-$24.13M
FY 2024derivedN/M FY24 yoy
-$0.05
Q3 2026N/M FY25 yoy
$22.32M
Q3 2026+18.6% FY25 yoy
$123.37M
—
1.8×
3.8×
—
—

Twelve months to Sep 30, 2026 · derived

Price

$4.3751.71%$4.68past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$61.86MFY 2025
$71.00M0FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$61,858,000reported
FY 20242024-12-31$56,134,000reported
FY 20232023-12-31$59,662,000reported
FY 20222022-12-31$70,995,000reported
FY 20212021-12-31$63,134,000reported
FY 20202020-12-31$44,531,000reported

Segments

Products
Revenue by Products, FY2020 to FY2025FY2020Exelderm · FY2020 · $4.45MOther · FY2020 · $40.08MFY2021Accutane · FY2021 · $10.05MExelderm · FY2021 · $5.36MOther · FY2021 · $47.72MFY2023Qbrexza · FY2023 · $25.41MAccutane · FY2023 · $20.17MOther / legacy · FY2023 · $5.92MAmzeeq · FY2023 · $6.20MOther · FY2023 · $1.96MFY2024Qbrexza · FY2024 · $25.11MAccutane · FY2024 · $19.41MFoam franchise products (Amzeeq & Zilxi) · FY2024 · $6.65MOther / legacy · FY2024 · $3.96MAmzeeq · FY2024 · $5.01MOther · FY2024 · $1.64MFY2025Qbrexza · FY2025 · $25.01MEmrosi · FY2025 · $14.75MAccutane · FY2025 · $12.88MFoam franchise products (Amzeeq & Zilxi) · FY2025 · $5.86MOther / legacy · FY2025 · $2.74M
LineFY2025ShareChange
Qbrexza$25.01M41%−0.4%
Emrosi$14.75M24%—
Accutane$12.88M21%−33.6%
Foam franchise products (Amzeeq & Zilxi)$5.86M9.6%−11.9%
Other / legacy$2.74M4.5%−30.9%
Amzeeq———
Exelderm———
Other———
Total$61.24M

From the 10-K filed Mar 26, 2026DERM

Pharmaceutical preparations

Journey Medical Corp is the 122nd largest of the 553 covered companies the SEC files under this code, by revenue. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Journey Medical Corp · CIK 1867066 · Engraved from SEC EDGAR